Covered recipient · General Payments record
DAWN J MARTIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021
$136.92
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $136.92 | 8 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Avanir Pharmaceuticals, Inc. | $38.47 | 2 |
| Mylan Specialty L.P. | $20.14 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.28 | 1 |
| Amarin Pharma Inc. | $16.85 | 1 |
| Clarus Therapeutics Inc. | $16.76 | 1 |
| Novo Nordisk AS | $14.50 | 1 |
| Genentech USA, Inc. | $12.92 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $136.92 | 8 |
Payment records · PY2021 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amarin Pharma Inc. | $16.85 | 09/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815439407 | CMS |
| Avanir Pharmaceuticals, Inc. | $20.16 | 11/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801054675 | CMS |
| Avanir Pharmaceuticals, Inc. | $18.31 | 11/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801056733 | CMS |
| Clarus Therapeutics Inc. | $16.76 | 10/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 855033153 | CMS |
| Genentech USA, Inc. | $12.92 | 10/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836021755 | CMS |
| Mylan Specialty L.P. | $20.14 | 11/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 965438439 | CMS |
| Novo Nordisk Inc | $14.50 | 10/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811483689 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.28 | 10/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 820543895 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.